News
11h
MedPage Today on MSNResearchers Detail Alarming Rise in GI Cancers Among Young PeopleIn addition to obesity, modifiable risk factors include a low-quality diet (such as high consumption of processed meats, ...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...
The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
(Reuters) -US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
A recent Turkish study published in Ophthalmic Epidemiology suggests the Pfizer-BioNTech COVID-19 vaccine may cause subtle ...
A new scientific study has found that Pfizer’s COVID-19 vaccine may cause temporary changes in the eyes’ corneal structure, ...
Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.
The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results